Skip to content

Effects of Neuromuscular Training on Functional Capacity in Acute Coronary Syndrome Patients

Effects of Neuromuscular Training on Functional Capacity in Acute Coronary Syndrome Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04246008
Enrollment
30
Registered
2020-01-29
Start date
2021-02-01
Completion date
2022-01-30
Last updated
2022-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Keywords

acute coronary syndrome, neuromuscular training, cardiac rehabilitation, functional capacity

Brief summary

The purpose of this study is to analyse the effects of neuromuscular training on functional capacity in patients with acute coronary syndrome, compared to the classic strength training of the cardiac rehabilitation programs

Detailed description

So far, there are no previous studies that analyze the effects of neuromuscular training on functional capacity in patients with acute coronary syndrome. Aim: The main objective of this study is to assess the effects of a 10 weeks neuromuscular training vs traditional strength training programme in patients with acute coronary syndrome. Design: Randomized clinical trial

Interventions

OTHERNeuromuscular training

The exercise training was developed based on assuring the correct performance of the exercise focusing in motor control.

The exercise training was developed based on standard strength training used in cardiac rehabiliation programmes

Sponsors

Cardenal Herrera University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

This is a mixed-design study. It includes a two-group parallel, randomized clinical trial with acute coronary syndrome patients.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Acute coronary syndrome patients * Physical activity must have been prescribed

Exclusion criteria

* inflammatory cardiac disease * severe or moderate ventricular dysfunction * heart failure * severe arrhytmias * systemic hypertension \>95% percentile * pulmonary hypertension \>40 mmHg * aortic stenosis * baseline O2 \<90% * severe valve insufficiency

Design outcomes

Primary

MeasureTime frameDescription
Incremental Shuttle Walking Test10 weeksMaximum distance reached

Secondary

MeasureTime frameDescription
30 seconds sit-to- stand test10 weeksNumber of repetitions
Changes in hip muscle strength10 weeksMeasured with dynamometer
Chester Step Test10 weeksTime performing the test
Sexual Health Inventory for Men10 weeksquestionnaire score
EQ-5D-5L10 weeksHealth Related Quality of Life measure
Cardiopulmonary exercise testing10 weeksMETS achieved in ergometry

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026